cdc-rfa-dd10-1004 foa final 06 07 10.doc

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)

Tourette Syndrome National Education and Outreach Program

I. AUTHORIZATION AND INTENT

Announcement Type: New – Type 1 Funding Opportunity Number: CDC-RFA-DD10-1004 Catalog of Federal Domestic Assistance Number: 93.184 Tourette Syndrome National Education and Outreach Program

Key Dates:

Application Submission Date: July 7, 2010 after date of PUBLICATION on Grants.gov, 11:59pm Eastern Standard Time (See full explanation in note found in Section V. Application Submission) Application Deadline Date: July 7, 2010, after date of PUBLICATION on Grants.gov, 11:59pm Eastern Standard Time

Authority:

This program is authorized under Sections 317(k)(2) and 317(C) of the Public Health Service Act [42 U.S.C. Sections 247b(k)(2) and 247b-4], as amended.

Purpose:

The purpose of the program is to provide support for a cooperative agreement to provide evidence based training and educational programs about Tourette Syndrome (TS) on both national and local levels. The programs should provide educational opportunities for audiences of medical and allied health professionals, educators, and the general public, including families, on appropriate diagnosis, co-occurring conditions, and best practices for treatment, and life management skills for children and adults with Tourette Syndrome. The education and outreach activities should incorporate both live and multimedia components and also have activities focusing on minority and underserved populations. Additionally, an evaluation component should be incorporated to measure the impact of all proposed activities on changes in knowledge and actual changes in practice as a result of medical and educational trainings, and dissemination of scientifically valid information. The activities will increase recognition and diagnosis of TS, decrease stigma associated with this condition, and increase provision and quality of healthcare services available for TS patients.

This program addresses the “Healthy People 2010” focus area(s) of Health Communication; Disability and Secondary Conditions; Mental Health and Mental Health Disorders.

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the National Center on Birth Defects and Developmental Disabilities: Improve the health and optimal development of all at risk children and all people with disabilities or potentially disabling conditions.

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm

II. PROGRAM IMPLEMENTATION

Recipient Activities for this program are as follows:

· Increase access on both national and local levels to accurate and scientifically valid information on the diagnosis and treatment of Tourette Syndrome in children and adults; impairment and family burden associated with TS; and disorders that commonly co-occur with TS, such as, but not limited to, obsessive compulsive disorder, and attention-deficit/hyperactivity disorder.

· Disseminate scientifically valid information on both national and local levels on the diagnosis and treatment of TS to health professionals, educators, allied professionals and families; provide information that reflects evidence-based knowledge and clinical practice; reduce misinformation and stigma where appropriate; respond to inquiries by individuals and families affected by TS; and respond to inquiries from the general public about TS.

· Develop, augment and modify education materials as necessary to increase access and dissemination of evidence based information to minority or underserved communities on Tourette Syndrome diagnosis and treatment specifically targeting medical, education, psychological providers and the public.

· Develop, augment and modify education materials as necessary to increase access and dissemination of evidence based information on Tourette Syndrome diagnosis and treatment specifically targeting families, including parents and youth impacted by Tourette Syndrome.

· Develop and implement an evaluation plan to assess the outcomes and impacts of all outreach and education activities. The evaluation plan may include both quantitative and qualitative methods, and should utilize rigorous evaluation design elements whenever possible (e.g., administering outcome measures both before and after participation in training to assess true change; and using previously validated measures). Outcomes and impacts to be assessed should include knowledge, attitudes, and behaviors related to TS. Specifically, the evaluation should include follow-up (longer-term) assessments of changes in practice by health-care providers, educators and families as a result of the information and skills obtained through the proposed outreach and education activities.

· Hire and train staff as necessary to implement education and outreach activities for Tourette Syndrome. Ensure that staff training curricula are models for similar health education training programs that can be applied to TS.

· Disseminate the information on Tourette Syndrome as widely as possible utilizing a multi-faceted approach to the targeted groups of healthcare providers, educators, allied professionals, the public and families. This should include both in-person training and dissemination of new or existing materials in different formats, including written, video, web-based, and CD formats in English and Spanish. Ensure the dissemination plan for the materials is developed, methods for reaching under-served and minority communities are described and justified, and accurate information on evidence-based diagnosis and treatment of Tourette Syndrome is available to all stakeholders.

In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.

CDC Activities for this program are as follows:

· Collaborate with recipient in setting program priorities as related to this cooperative agreement, in particular in the development of training and educational programs for medical and allied health professionals as well as the general public, including families.

· Review and provide scientific expertise in evaluating the validity of educational materials developed by medical and scientific advisors that reflects evidence-based knowledge and change in clinical practice.

· In conjunction with recipient, participate in the development of all educational and training materials, focusing on the appropriateness for the target audience.

· Provide technical and scientific assistance for the evaluation of all proposed outreach and educational activities, including assistance with analysis of de-identified data, if requested.

· Facilitate the exchange of program information and the development of partnerships between the recipient funded under this announcement and other federal agencies, community organizations, health departments, and other partners.

III. AWARD INFORMATION AND REQUIREMENTS

Type of Award: Cooperative Agreement.

CDC substantial involvement in this program appears in the Activities Section above.

Award Mechanism: U38

Fiscal Year Funds: 2010 Approximate Current Fiscal Year Funding: $800,000

Approximate Total Project Period Funding: $2,400,000 (This amount is an estimate and includes direct and indirect costs and is subject to availability of funds.)

Approximate Number of Awards: 1 Approximate Average Award: $800,000 (This amount is for the first 12-month budget period, and includes direct and indirect costs.)

Floor of Individual Award Range: None Ceiling of Individual Award Range: $800,000 (This ceiling is for the first 12-month budget period and includes direct and indirect cost.)

Anticipated Award Date: September 1, 2010

Budget Period Length: 12 months Project Period Length: 3 years Throughout the project period, CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government.

IV. ELIGIBILITY

Eligible applicants that can apply for this funding opportunity are listed below:

· Nonprofit with 501C3 IRS status (other than institution of higher education)

· Nonprofit without 501C3 IRS status (other than institution of higher education)

· For-profit organizations (other than small business)

· Small, minority, and women-owned businesses

· Universities

· Colleges

· Research institutions

· Hospitals

· Community-based organizations

· Faith-based organizations

· Federally recognized or state-recognized American Indian/Alaska Native tribal governments

· American Indian/Alaska native tribally designated organizations

· Alaska Native health corporations

· Urban Indian health organizations

· Tribal epidemiology centers

· State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)

· Political subdivisions of States (in consultation with States)

· Non-domestic (non-U.S.) entity

· Other (specify)

A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via www.grants.gov.

SPECIAL ELIGIBILITY CRITERIA: Licensing/Credential/Permits Cost Sharing or Matching Cost sharing or matching funds are not required for this program.

Maintenance of Effort

Maintenance of Effort is not required for this program.

Other

If a funding amount greater than the ceiling of the award range is requested, the application will be considered non-responsive and will not be entered into the review process. The applicant will be notified that the application did not meet the eligibility requirements.

Special Requirements:

If applicant identifies themselves as a non-profit 501 (c) (3) organization, proof of non-profit 501(c) (3) status is required in application appendix.

Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

V. Application Content

Unless specifically indicated, this announcement requires submission of the following information: Table of contents

A Project Abstract must be completed in the Grants.gov application forms. The project abstract must be submitted in the following format:

· Maximum of one Page

· Font Size; 12 point unreduced, Times New Roman

· Single Spaced

· Paper size: 8.5 by 11 inches

· Page margin Size: one Inch

The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. The abstract must not include any proprietary/confidential information.

A Project Narrative must be submitted with the application forms. The project narrative must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format:

· Maximum number of pages: 25 If the narrative exceeds the page limit, only the first pages which are within the page limit will be reviewed.

· Font size: 12 point unreduced, Times New Roman

· Single spaced

· Paper size: 8.5 by 11 inches

· Page margin size: One inch

· Number all pages of the application sequentially from page 1 (Application Face Page) to the end of the application, including charts, figures, tables, and appendices.

· Printed only on one side of page.

· Held together only by rubber bands or metal clips; not bound in any other way.

The narrative should address activities to be conducted over the entire project period and must include the following items in the order listed:

Background and Need

Applicant must:

· Demonstrate understanding and experience relevant to the purpose of the proposal; demonstrate expertise in Tourette Syndrome; demonstrate having an established network of medical, scientific, and educational professionals who are recognized as national experts in TS; demonstrate having an established network of local TS organizations that can assist with referrals and dissemination of informational materials on TS.

Goals and Objectives

Applicant must include:

· Measurable goals that are relevant to the purpose of the proposal which can be accomplished during the project period;

· Objectives which address activities necessary to accomplish the purpose of the proposal and can be accomplished during the budget period and project period.

Methods

Applicant must provide:

· A detailed description of proposed activities for the budget period which are likely to achieve each objective and overall program goals;

· A reasonable and complete schedule for implementing all activities for the program period;

· Evidence the applicant has in existence evidence-based information and informational materials, which can be used in trainings, and capacity to improve those materials. This can be demonstrated by submitting examples of such materials either by web-link(s) or attachment. The materials should include content on diagnosis, co-occurring conditions, pharmaceutical and behavioral treatments (including comprehensive behavioral intervention for tics), and information for educators and other school personnel on strategies for teaching children with TS.

· A detailed description demonstrating having an established information system coordinated by trained professionals with expertise in TS, as well as an established system of widely disseminating evidence-based information and trainings about TS across the nation to medical, educational, psychological and other allied professionals.

· An established list of providers who can provide scientifically accurate diagnostic and treatment information about TS to the public.

Evaluation

Applicant must:

· Describe the proposed evaluation design, data sources, data collection methods, and data analysis plan to assess the outcomes and/or impacts of all proposed activities;

· Demonstrate capability for accessing, obtaining or collecting necessary outcome and/or impact data;

· Document staff availability, expertise, experience, and capacity to conduct the proposed evaluation and analyze the data;

Organizational Structure and Staffing

Applicant must provide:

· A description of the roles of each unit, organization, or agency;

· Evidence of qualifications, supervision, and degree of commitment of staff, organizations, and/or agencies involved in activities.

· Applicant should be able to demonstrate capacity and experience in conducting TS trainings to both health care providers and educators in all 50 states; demonstrate capacity to build upon previous TS medical and educational training across the nation, specifically, ability to reach different types of health care providers, school personnel, and minority and underserved populations. This can be demonstrated by submitting a list of trainings recently conducted either by attachment or web-link.

Budget and Justification:

Applicant must provide:

· A detailed budget

· Justification consistent with stated objectives and planned program activities.

Additional information may be included in the application appendices. The appendices will not be counted toward the narrative page limit. This additional information includes:

· Curriculum Vitae, Resumes, Organizational Charts, and Letters of Support, etc.

Additional information submitted via www.Grants.gov should be uploaded in a PDF file format, and should be named:

· Additional-Info

No more than 3 supplementary documents should be uploaded per application.

Additional requirements for additional documentation with the application are listed in Section VII. Award Administration Information; subsection entitled “Administrative and National Policy Requirements.”

APPLICATION SUBMISSION

Registering the organization through www.Grants.gov, the official agency-wide E-grant website, is the first step in submitting an application online. Registration information is located on the “Get Registered” screen of www.Grants.gov. Please visit www.Grants.gov at least 30 days prior to submitting your application to familiarize yourself with the registration and submission processes. The “one-time” registration process will take three to five days to complete. However, the www.Grants.gov registration process also requires registering the organization with the Central Contractor Registry (CCR) annually. The CCR registration can require an additional one to two days to complete.

Submit the application electronically by using the forms and instructions posted for this funding opportunity on www.Grants.gov. If the applicant encounters difficulty in accessing the forms on-line, contact the HHS/CDC Procurement and Grant Office Technical Information Management Section (PGO-TIMS) staff at (770) 488-2700 for further instruction.

Note: Application submission is not concluded until successful completion of the validation process.

After submission of your application package, applicants will receive a “submission receipt” email generated by Grants.gov. Grants.gov will then generate a second e-mail message to applicants which will either validate or reject their submitted application package. This validation process may take as long as two (2) business days. Applicants are strongly encouraged check the status of their application to ensure submission of their application package is complete and no submission errors exists. To guarantee that you comply with the application deadline published in the Funding Opportunity Announcement, applicants are also strongly encouraged to allocate additional days prior to the published deadline to file their application. Non-validated applications will not be accepted after the published application deadline date.

In the event that you do not receive a “validation” email within two (2) business days of application submission, please contact Grants.gov. Refer to the email message generated at the time of application submission for instructions on how to track your application or the Application User Guide, Version 3.0 page 57.

Other Submission Requirements

Letter of intent is not applicable to this funding opportunity announcement.

Dun and Bradstreet Universal Number (DUNS)

The applicant is required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) identifier to apply for grants or cooperative agreements from the Federal government. The DUNS is a nine-digit number which uniquely identifies business entities. There is no charge associated with obtaining a DUNS number. Applicants may obtain a DUNS number by accessing the Dun and Bradstreet website or by calling 1-866-705-5711.

Electronic Submission of Application:

Applications must be submitted electronically at www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully submitted electronically by the applicant organization’s Authorized Organizational representative (AOR) to Grants.gov on or before the deadline date and time.

The application package can be downloaded from www.Grants.gov. Applicants can complete the application package off-line, and then upload and submit the application via the Grants.gov Web site. The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable by staff.

Applications submitted through www.Grants.gov are electronically time/date stamped and assigned a tracking number. The AOR will receive an e-mail notice of receipt when HHS/CDC receives the application. The tracking number serves as a receipt of submission.

If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it’s needed. You can reach the Grants.gov Support Center at 1-800-518-4726 or by email at support@grants.gov. Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.

Submission Dates and Times

This announcement is the definitive guide on the application content, submission, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline published herein, it will not be eligible for review and the applicant will be notified the application did not meet the submission requirements. The application face page will be returned by HHS/CDC with a written explanation of the reason for non-acceptance.

Application Submission Date: July 7, 2010, after date of PUBLICATION on Grants.gov (See full explanation in note found in Section V. Application Submission) Application Deadline Date: July 7, 2010, after date of PUBLICATION ON GRANTS.GOV, 11:59pm Eastern Standard Time. Explanation of Deadlines:

VI. Application Review Information

Eligible applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the DD10-1004. Measures of effectiveness must relate to the performance goals stated in the “Purpose” section of this announcement. Measures of effectiveness must be objective, quantitative and measure the intended outcome of the proposed program. The measures of effectiveness must be included in the application and will be an element of the evaluation of the submitted application.

Evaluation Criteria Eligible applications will be evaluated against the following criteria:

Background and Need (35 Points): Extent to which the applicant understands the requirements, problems, objectives, complexities, and interactions required of this cooperative agreement. This includes the applicant’s capacity to demonstrate expertise in Tourette Syndrome; Extent to which applicant demonstrates having an established network of medical, scientific, and educational professionals who are recognized as national experts in TS; Extent to which applicant demonstrates having an established network of local TS organizations that can assist with referrals and dissemination of informational materials on TS. Extent to which applicant demonstrates experience with outreach to minorities or underserved populations.

Goals and Objectives (20 Points): Degree to which proposed goals and objectives are clearly stated, realistic, achievable, measurable, feasible within the project period, time-phased, and relevant to the purpose of this project.

Methods (20 Points): Feasibility of the proposed methods including provision of sufficient detail for plans and implementation schedule to evaluate whether goals and objectives are achievable within the budget period; Extent to which the applicant will accomplish the program goals; Extent to which applicant can demonstrate having in existence evidence-based information and informational materials on TS diagnosis, treatment, and education, which can be used in training, and applicant’s capacity to improve those materials; Extent to which applicant can demonstrate having an established information and referral system of trained professionals with expertise in TS; Extent to with applicant can demonstrate having an established system to widely disseminate evidence based information and trainings about TS locally and across the nation to medical, educational, psychological and other allied professionals, as well as the public.

Evaluation (15 Points): Feasibility of the evaluation plan; Adequacy of evaluation methods to measure program performance in accordance with objectives listed in this proposal , including sufficient detail on design, data collection and analysis; Extent to which applicant demonstrates capacity and expertise to collect necessary data; Sufficient rigor in the evaluation design given the nature of the activities and the resources (including time) available; Suitability of the evaluation design to allow for conclusions about the outcomes and/or impacts of all proposed activities. Extent to which measures of effectiveness will demonstrate the accomplishments of the identified goals and objectives and appropriately track performance and progress.

Organizational Structure and Staffing (10 Points) Extent to which personnel involved in this project are qualified and have appropriate experience. Extent to which applicant demonstrates experience and knowledge in TS. Extent to which applicant demonstrates capacity and experience in conducting TS trainings local and nation-wide to both health care providers and educators. Extent to which applicant demonstrates capacity to build upon previous TS medical and educational training across the nation, specifically, ability to reach different types of health care providers, school personnel, and minority and underserved populations. Extent to which the staff roles are clearly defined. Extent to which the staff as described will be sufficient to accomplish the program goals.

Budget (SF 424A) and Budget Narrative (Reviewed, but not scored). Although the budget is not scored applicants should consider the following in development of their budget. Is the itemized budget for conducting the project, and justification reasonable and consistent with stated objectives and planned program activities?

If the applicant requests indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. The indirect cost rate agreement should be uploaded as a PDF file with “Other Attachment Forms” when submitting via Grants.gov.

Funding Restrictions Restrictions, which must be taken into account while writing the budget, are as follows:

· Recipients may not use funds for research.

· Recipients may not use funds for clinical care.

· Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

· Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

· The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

The applicant can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address:

http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

Application Review Process

All eligible applications will be initially reviewed for completeness by the Procurement and Grants Office (PGO) staff. In addition, eligible applications will be jointly reviewed for responsiveness by National Center on Birth Defects and Developmental Disabilities and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet eligibility and/or published submission requirements.

An objective review panel will evaluate complete and responsive applications according to the criteria listed in Section VI. Application Review Information, subsection entitled “Evaluation Criteria”. The objective review process will follow the policy requirements as stated in the GPD 2.04 at http://198.102.218.46/doc/gpd204.doc.

Applications Selection Process

Applications will be funded in order by score and rank determined by the review panel.

CDC will provide justification for any decision to fund out of rank order.

VII. Award Administration Information Award Notices

Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application.

Unsuccessful applicants will receive notification of the results of the application review by mail.

Administrative and National Policy Requirements

Successful applicants must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) Part 74 or Part 92, as appropriate. The following additional requirements apply to this project:

· AR-9

Paperwork Reduction Act Requirements

· AR-10

Smoke-Free Workplace Requirements

· AR-11

Healthy People 2010

· AR-12

Lobbying Restrictions

· AR-15

Proof of Non-Profit Status

Additional information on the requirements can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.

For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm

TERMS AND CONDITIONS

Reporting Requirements

Each funded applicant must provide CDC with an annual Interim Progress Report submitted via www.grants.gov:

1. The interim progress report is due no less than 90 days before the end of the budget period. The Interim Progress Report will serve as the non-competing continuation application, and must contain the following elements:

a. Standard Form (“SF”) 424S Form

b. SF-424A Budget Information-Non-Construction Programs

c. Budget Narrative

d. Indirect Cost Rate Agreement

e. Project Narrative

f. Identify Estimated Unobligated Funds in the current budget period by component separately on the 424A Forms and provide detail actions to be taken to obligate the funds.

Additionally, funded applicants must provide CDC with an original, plus two hard copies of the following reports:

2. Financial Status Report (SF 269: and annual progress report, no more than 90 days after the end of the budget period.

3. Final performance and Financial Status Reports, no more than 90 after the end of the project period.

The reports must be submitted to the attention of the Grants Management Specialist listed in the Section VIII below entitled “Agency Contacts”.

VIII. Agency Contacts

CDC encourages inquiries concerning this announcement.

For programmatic technical assistance, contact:

D. Camille Smith, Project Officer

Department of Health and Human Services

Centers for Disease Control and Prevention

[1600 Clifton Road NE MS: E-88

Atlanta, Georgia 30333]

Telephone: 404-498-3007

E-mail:cas0@cdc.gov

For financial, grants management, or budget assistance, contact:

Tracey Sims, Grants Management Specialist

CDC Procurement and Grants Office

2920 Brandywine Road, MS [E-09]

Atlanta, GA 30341

Telephone: (770) 488-2379

E-mail:atu9@cdc.gov

For general questions, contact:

Technical Information Management Section –DD10-1004

CDC Procurement and Grants Office

2920 Brandywine Road, MS E-14

Atlanta, GA 30341

Telephone: 770-488-2700

Email:

pgotim@cdc.gov

CDC Telecommunications for the hearing impaired or disabled is available at: TTY 770-488-2783.

Other Information

Other CDC funding opportunity announcements can be found on the CDC Web site, Internet address: http://www.grants.gov/

PAGE